Literature DB >> 23541630

Examining renal impairment as a risk factor for acute coronary syndrome: a prospective observational study.

Jaimi H Greenslade1, Louise Cullen, Lauren Kalinowski, William Parsonage, Suetonia Palmer, Sally Aldous, Mark Richards, Kevin Chu, Anthony F T Brown, Richard Troughton, Chris Pemberton, Martin Than.   

Abstract

STUDY
OBJECTIVE: This study seeks to examine whether the finding of an abnormal estimated glomerular filtration rate (eGFR) in the emergency department (ED) was associated with acute coronary syndrome in the population of patients presenting for investigation of chest pain.
METHODS: We used prospectively collected data on adult patients presenting with suspected acute coronary syndrome to 2 EDs in Australia and New Zealand. Trained research nurses collected clinical data with a customized case report form. Creatinine measurements were taken on presentation, and the glomerular filtration rate ([GFR]; milliliters per minute per 1.73 m(2)) was estimated with the chronic kidney disease epidemiologic collaboration equation. The primary endpoint was acute coronary syndrome within 30 days of presentation, as adjudicated by cardiologists using standardized guidelines. Logistic regression analyses examined the relationship between eGFR and acute coronary syndrome.
RESULTS: Acute coronary syndrome was diagnosed in 421 (21%) of the 1,968 patients recruited. Compared with patients with an eGFR greater than 90 mL/minute per 1.73 m(2), patients with an eGFR between 60 and 90 mL/minute per 1.73 m(2) and patients with an eGFR less than 60 mL/minute per 1.73 m(2) were 1.64 (95% confidence interval 1.10 to 2.44) and 1.70 (95% confidence interval 1.01 to 2.77) times more likely to receive a diagnosis of acute coronary syndrome after controlling for age, sex, hypertension, dyslipidemia, family history of cardiac disease, diabetes, patient history of cardiac disease, cardiac troponin level, and ECG findings.
CONCLUSION: There is an independent association between eGFR and acute coronary syndrome risk in patients presenting to the ED with chest pain; this association is independent of age, traditional cardiac risk factors, medical history, troponin level, and ECG findings. Reduced eGFR should be considered an acute coronary syndrome risk factor, and clinicians should maintain high clinical suspicion for acute coronary syndrome in patients with abnormal renal function results regardless of whether they have known kidney disease, traditional acute coronary syndrome risk factors, or abnormal diagnostic test results. Risk stratification tools should include reduced eGFR as a high-risk feature.
Copyright © 2013 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541630     DOI: 10.1016/j.annemergmed.2013.01.011

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

1.  Analysis of the Clinical Characteristics of Patients with Acute Coronary Syndrome in Different States of Renal Function.

Authors:  L-H Hu; L-J Zhang; Z-T Jin; W Yang; L-N Zhang; C-Y Lu
Journal:  West Indian Med J       Date:  2015-05-06       Impact factor: 0.171

2.  Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department.

Authors:  Peter A Kavsak; Johannes T Neumann; Louise Cullen; Martin Than; Colleen Shortt; Jaimi H Greenslade; John W Pickering; Francisco Ojeda; Jinhui Ma; Natasha Clayton; Jonathan Sherbino; Stephen A Hill; Matthew McQueen; Dirk Westermann; Nils A Sörensen; William A Parsonage; Lauren Griffith; Shamir R Mehta; P J Devereaux; Mark Richards; Richard Troughton; Chris Pemberton; Sally Aldous; Stefan Blankenberg; Andrew Worster
Journal:  CMAJ       Date:  2018-08-20       Impact factor: 8.262

3.  Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study.

Authors:  Qinglu Cheng; Jaimi H Greenslade; William A Parsonage; Adrian G Barnett; Katharina Merollini; Nicholas Graves; W Frank Peacock; Louise Cullen
Journal:  BMJ Open       Date:  2016-02-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.